Understand the challenges and impacts of the 3Rs on animal welfare in research with Dr. Liz Nunamaker's expert interview.

What if you could actually see where a drug travels in the body down to the cellular level. Find out how mass spectrometry ...

Stanford scientists have successfully grown heart and liver organoids that include functioning blood vessels. This ...

Discover how SB000 offers a safe alternative for cell rejuvenation without activating dangerous pluripotency pathways.

Learn about the innovative method to create aptamers that could revolutionise treatments for infectious diseases.

Explore the potential of protein design with the new deep learning approach from Chongqing University to enhance binding ...

Explore GPCR-targeting therapies and their untapped potential in drug development, making up 30-35 percent of approved drugs.

Learn how antibody to payload design is crucial for advancing ADC technology in oncology and beyond with expert insights.

Learn how radiopharmaceuticals are transforming nuclear medicine and cancer therapy through targeted diagnostics and ...

Explore the collaboration between lab and data scientists to overcome communication challenges in life sciences.

Cytokine release syndrome (CRS) is a major barrier in cancer immunotherapy – but what if we could prevent it before it begins? Dr Liam Tremble, Principal Scientist at Poolbeg Pharma, discusses how ...

Scientists have developed a new drug, SHP1705, that targets hijacked circadian clock proteins used by glioblastoma stem cells to grow and resist treatment. Glioblastoma, the most aggressive form of ...